VistaPharm Recalls Lactulose Solution Due to Microbial Contamination
VistaPharm is recalling Lactulose Solution, USP, because the product failed microbial testing for yeast and mold counts.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses or injuries, fitting the criteria for a moderate severity score involving low-risk contamination or voluntary precautionary measures.
Plain-English summary
VistaPharm, Inc. is recalling Lactulose Solution, USP, 20 g/30 mL, packaged in 50-unit dose cups per case. The recall involves 9,945 cases of the product manufactured in Largo, Florida.
The recall was initiated because the product failed the Total Yeast/Mold Count specification, indicating microbial contamination of the non-sterile product. The affected lots are 458300 (Exp 09/2018), 462600 (Exp 07/2018), 471000 (Exp 10/2018), and 474300 (Exp 11/2018).
The product was distributed in California, Illinois, Louisiana, New Hampshire, Ohio, Pennsylvania, and South Carolina. Consumers should check their medication for these specific lot numbers and expiration dates. If the product matches the recalled lots, consumers should stop using it and contact their healthcare provider or pharmacist for guidance.
The recalled product
- Product
- Lactulose Solution, USP, 20 g/30 mL, dose cups delivers 30 mL packaged 50-unit dose cups per case, Manufactured by VistaPharm, Inc., Largo, FL 33771, NDC 66689-038-01
- Manufacturer
- VistaPharm, Inc.
- Category
- Drug — Oral Solution
- Affected units
- 9,945
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lot #: 458300
- Exp 09/2018
- 462600
- Exp 07/2018
- 471000
- Exp 10/2018
- 474300
- Exp 11/2018
Distribution
Part of a larger recall action
This product is one of 2 recalled by VistaPharm, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · VistaPharm, Inc.
See all →- ModeratePrescription pyridostigmine bromide oral solution recalled for out-of-specification preservative
FDA (Drugs) · 2022-11-02
- ModerateClobazam Oral Suspension Recalled for Failed Stability Specifications
FDA (Drugs) · 2022-01-26
- LowVistaPharm Recalls Nystatin Oral Suspension Due to Impurity
FDA (Drugs) · 2020-10-14
- LowVistaPharm Recalls Nystatin Oral Suspension Due to Impurity Exceeding Specifications
FDA (Drugs) · 2020-07-15
- LowVistaPharm Recalls Nystatin Oral Suspension Due to Impurity Peak
FDA (Drugs) · 2020-07-15
Same hazard · microbial contamination
See all →- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- SevereMedline Ultrasound Breast Pack Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- HighMedline Convenience Kits Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- CriticalOptimal Balance Pharmacy Recalls Contaminated Glutathione Injection Vials
FDA (Drugs) · 2026-09-09
Similar recalls
- SevereVistaPharm Recalls Lactulose Solution Due to Bacterial Contamination
FDA (Drugs) · 2016-11-30
- SevereVistaPharm Recalls Lactulose Solution Due to Potential Bacterial Contamination
FDA (Drugs) · 2017-02-08
- LowVistaPharm Recalls Metoclopramide Oral Solution Due to Defective Container Lids
FDA (Drugs) · 2015-10-07
- LowVistaPharm Recalls Metoclopramide Oral Solution Due to Labeling Error
FDA (Drugs) · 2012-09-05
- SevereVistaPharm Recalls Xactdose Phenytoin Oral Suspension Due to Container Defects
FDA (Drugs) · 2012-08-08
- LowVistaPharm Recalls Nystatin Oral Suspension Due to Impurity
FDA (Drugs) · 2020-10-14